Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Mitsubishi-Tokyo Pharmaceuticals reports synthesis and activity of imidazole M3 antagonists

Nov. 6, 2000

Single-dose rhIL-10 does not alter responses to allergen challenge in asthmatics

Nov. 6, 2000

First clinical trial of EPI-2010 for asthma

Nov. 6, 2000

AstraZeneca presents potential new antirhinitis and antiasthma agents

Nov. 3, 2000

Discovery awarded fast track SBIR grant for Surfaxin development

Nov. 3, 2000

Pharmacological characterization of novel antiasthmatic agent NIP-520

Nov. 2, 2000

Bioavailability of new 5-LO inhibitor CJ-13610 in dogs and humans

Oct. 31, 2000

Banyu claims new series of piperidine chemokine antagonists

Oct. 27, 2000

Hepatic metabolism of ciclesonide discussed at Xenobiotics meeting in Japan

Oct. 27, 2000

Dainippon describes new, water-soluble neutrophil elastase inhibitors

Oct. 26, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...